U.S. Bank acquires healthcare payments platform Salucro Healthcare Solutions
U.S. Bank (NYSE: USB) has acquired Salucro Healthcare Solutions , a leading healthcare financial technology company specializing in patient payments and billing. This acquisition expands U.S. Bank's focus on the healthcare industry, complementing its existing services. Salucro, founded in 2004 and based in Tempe, Arizona, was previously a partner of Elavon, U.S. Bank's merchant acquiring unit. The bank had initially invested in Salucro in 2022, with Salucro's platform being sold through Elavon as MedEpay.
The acquisition closed on August 21, 2024, with Salucro team members integrating into Elavon. This move strengthens U.S. Bank's position in providing banking and payment services to healthcare organizations, including hospital systems, insurers, and medical practices.
U.S. Bank (NYSE: USB) ha acquisito Salucro Healthcare Solutions, una delle principali aziende di tecnologia finanziaria nel settore sanitario specializzata nei pagamenti e nella fatturazione dei pazienti. Questa acquisizione amplia il focus di U.S. Bank sull'industria sanitaria, complementando i suoi servizi esistenti. Salucro, fondata nel 2004 e con sede a Tempe, in Arizona, era in precedenza un partner di Elavon, l'unità di acquisizione commercianti di U.S. Bank. La banca aveva inizialmente investito in Salucro nel 2022, con la piattaforma di Salucro venduta tramite Elavon come MedEpay.
L'acquisizione si è conclusa il 21 agosto 2024, con i membri del team di Salucro che si integrano in Elavon. Questa mossa rafforza la posizione di U.S. Bank nel fornire servizi bancari e di pagamento alle organizzazioni sanitarie, inclusi i sistemi ospedalieri, gli assicuratori e le pratiche mediche.
U.S. Bank (NYSE: USB) ha adquirido Salucro Healthcare Solutions, una empresa líder en tecnología financiera en el sector de la salud especializada en pagos y facturación de pacientes. Esta adquisición amplía el enfoque de U.S. Bank en la industria de la salud, complementando sus servicios existentes. Salucro, fundada en 2004 y con sede en Tempe, Arizona, era anteriormente un socio de Elavon, la unidad de adquisición de comerciantes de U.S. Bank. El banco había invertido inicialmente en Salucro en 2022, siendo la plataforma de Salucro comercializada a través de Elavon como MedEpay.
La adquisición se cerró el 21 de agosto de 2024, con los miembros del equipo de Salucro integrándose en Elavon. Este movimiento fortalece la posición de U.S. Bank en la prestación de servicios bancarios y de pago a organizaciones de salud, incluidos sistemas hospitalarios, aseguradoras y prácticas médicas.
U.S. Bank (NYSE: USB)는 Salucro Healthcare Solutions을 인수했습니다. 이는 환자 결제 및 청구를 전문으로 하는 선도적인 의료 금융 기술 회사입니다. 이 인수는 U.S. Bank의 의료 산업에 대한 집중을 확대하며 기존 서비스들을 보완합니다. Salucro는 2004년에 설립되었고 아리조나주 템프에 본사를 두고 있으며, 이전에 U.S. Bank의 상인 인수 부서인 Elavon의 파트너였습니다. 은행은 2022년에 Salucro에 초기 투자를 하였고, Salucro의 플랫폼은 Elavon을 통해 MedEpay로 판매되었습니다.
인수는 2024년 8월 21일에 완료되었고 Salucro의 팀원들이 Elavon에 통합되었습니다. 이번 조치는 U.S. Bank가 병원 시스템, 보험사 및 의료 행위 등 의료 기관에 은행 및 결제 서비스를 제공하는 입지를 강화합니다.
U.S. Bank (NYSE: USB) a acquis Salucro Healthcare Solutions, une entreprise leader dans la technologie financière du secteur de la santé, spécialisée dans les paiements et la facturation des patients. Cette acquisition élargit l'orientation de U.S. Bank vers l'industrie de la santé, complétant ses services existants. Salucro, fondée en 2004 et basée à Tempe, en Arizona, était auparavant un partenaire d'Elavon, l'unité d'acquisition de commerçants de U.S. Bank. La banque avait initialement investi dans Salucro en 2022, la plateforme de Salucro étant vendue via Elavon sous le nom de MedEpay.
L'acquisition a été finalisée le 21 août 2024, les membres de l'équipe de Salucro s'intégrant dans Elavon. Ce mouvement renforce la position de U.S. Bank dans la fourniture de services bancaires et de paiement aux organisations de santé, y compris les systèmes hospitaliers, les assureurs et les pratiques médicales.
U.S. Bank (NYSE: USB) hat Salucro Healthcare Solutions übernommen, ein führendes Unternehmen für Finanztechnologie im Gesundheitswesen, das auf Patientenzahlungen und Rechnungswesen spezialisiert ist. Diese Akquisition erweitert den Fokus von U.S. Bank auf die Gesundheitsbranche und ergänzt die bestehenden Dienstleistungen. Salucro wurde 2004 gegründet und hat seinen Hauptsitz in Tempe, Arizona. Zuvor war es Partner von Elavon, der Händlerakquisitionssparte von U.S. Bank. Die Bank hatte 2022 erstmals in Salucro investiert, wobei die Plattform von Salucro über Elavon als MedEpay verkauft wurde.
Die Übernahme wurde am 21. August 2024 abgeschlossen, wobei die Mitarbeiter von Salucro in Elavon integriert werden. Dieser Schritt stärkt die Position von U.S. Bank bei der Bereitstellung von Bank- und Zahlungsdiensten für Gesundheitseinrichtungen, einschließlich Krankenhausnetzwerken, Versicherern und Arztpraxen.
- Acquisition of Salucro expands U.S. Bank's healthcare industry focus
- Salucro's platform complements existing U.S. Bank and Elavon offerings
- Integration of Salucro team into Elavon strengthens U.S. Bank's healthcare services
- None.
Insights
U.S. Bank's acquisition of Salucro Healthcare Solutions marks a strategic expansion in the lucrative healthcare payments sector. This move is likely to enhance U.S. Bank's revenue streams and market share in the healthcare industry. The integration of Salucro's platform with Elavon's existing services could create synergies and potentially boost profit margins. While financial terms weren't disclosed, the acquisition's impact on U.S. Bank's bottom line will be important to monitor in upcoming earnings reports. Investors should watch for improved operational efficiency and cross-selling opportunities that could drive growth in the bank's healthcare-focused services.
The acquisition of Salucro significantly strengthens U.S. Bank's position in the healthcare financial technology space. Salucro's expertise in patient payments and billing addresses a critical need in the industry, especially as healthcare providers seek to streamline financial operations and improve patient experience. This move aligns with the growing trend of digitalization in healthcare finance. The integration of Salucro's platform with U.S. Bank's existing services could lead to more comprehensive and efficient solutions for healthcare providers, potentially reducing administrative costs and improving cash flow management. This acquisition positions U.S. Bank to capitalize on the ongoing digital transformation in healthcare payments.
This acquisition reflects U.S. Bank's strategic focus on the healthcare sector, a market with significant growth potential. The healthcare payments industry is projected to expand due to factors like an aging population and increasing healthcare costs. By integrating Salucro's technology, U.S. Bank is poised to capture a larger share of this growing market. The move also demonstrates U.S. Bank's commitment to innovation and digital solutions, which could enhance its competitive edge. Investors should consider the long-term growth prospects this acquisition brings, particularly in terms of customer retention and expansion of services within the healthcare industry. The success of this integration will be a key indicator of U.S. Bank's ability to execute its healthcare-focused strategy.
Acquisition further expands bank’s focus on healthcare industry
Founded in 2004, Salucro is a market leader in providing online billing and payments offerings for healthcare providers across
“U.S. Bank is a leader in providing banking and payments services to the healthcare industry, making it easier for providers and patients to focus on what’s most important to them,” said Shailesh Kotwal, vice chair of
This acquisition builds on the bank’s more than a century of service to healthcare-focused clients.
The Salucro team members are now employees of
The acquisition closed on Aug. 21, 2024. Financial terms are not disclosed.
For more about
About U.S. Bancorp
U.S. Bancorp, with more than 70,000 employees and
Deposit products are offered by
Services may be subject to credit approval. Eligibility requirements, restrictions and fees may apply. See a business banker for details.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240822054081/en/
Joe Rauch,
joseph.rauch@usbank.com
Source: U.S. Bancorp
FAQ
What company did U.S. Bank (USB) acquire in the healthcare payments sector?
When did U.S. Bank (USB) complete the acquisition of Salucro Healthcare Solutions?
How does the Salucro acquisition benefit U.S. Bank's (USB) healthcare services?
What is the relationship between Salucro and U.S. Bank's (USB) Elavon unit?
